Received: 2 December 2021
Accepted: 29 January 2022
First Online: 19 February 2022
: The study was approved by the Ethics Committee of the Helsinki University Hospital and conducted according to the Declaration of Helsinki. Informed consent was received from each subject.
: Consent for publication was received.
: Hanna Harno has provided consultancy to TEVA, Allergan, and Lilly, unrelated to this work. None of the other co-authors have conflicts of interest to disclose.